Effects of hepatitis B virus infection on the interferon response in immunodeficient human hepatocyte chimeric mice

Journal of Infectious Diseases

Volumn 204, Issue 2, 2011, Pages 224-228

  Tsuge, Masataka ^a,b   Takahashi, Shoichi ^a,b   Hiraga, Nobuhiko ^a,b   Fujimoto, Yoshifumi ^a,c   Zhang, Yizhou ^a,b   Mitsui, Fukiko ^a,b   Abe, Hiromi ^a,c   Kawaoka, Tomokazu ^a,b   Imamura, Michio ^a,b   Ochi, Hidenori ^a,b,c   Hayes, C Nelson ^a,b   Chayama, Kazuaki ^a,b,c  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c RIKEN   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; COMPLEMENTARY DNA; INTERFERON; VIRUS DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE REPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC REGULATION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INNATE IMMUNITY; LIVER CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TREATMENT RESPONSE;

ANIMALS; GENE EXPRESSION PROFILING; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; INTERFERONS; MICE; MICE, SCID; MICROARRAY ANALYSIS;

EID: 79958759913     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir247     Document Type: Article

References (15)

1. Hsu HY, Tsai HY, Wu TC, et al. Interferon-alpha treatment in children and young adults with chronic hepatitis B: a long-term follow-up study in Taiwan. Liver Int 2008; 28:1288-97.
2. Lin SM, Tai DI, Chien RN, Sheen IS, Chu CM, Liaw YF. Comparison of long-term effects of lymphoblastoid interferon alpha and recombinant interferon alpha-2a therapy in patients with chronic hepatitis B. J Viral Hepat 2004; 11:349-57.
3. Sung JJ, Tsoi KK, Wong VW, Li KC, Chan HL. Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma. Aliment Pharmacol Ther 2008; 28:1067-77.
4. Bigger CB, Brasky KM, Lanford RE. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 2001; 75:7059-66. (Pubitemid 32641593)
5. Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Kaneko S. Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C. Hepatology 2006; 44:1122-38. (Pubitemid 44748364)
6. Okabe H, Satoh S, Kato T, et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001; 61:2129-37. (Pubitemid 32692038)
7. Mercer DF, Schiller DE, Elliott JF, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 2001; 7:927-33. (Pubitemid 32756430)
8. Tateno C, Yoshizane Y, Saito N, et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am J Pathol 2004; 165:901-12. (Pubitemid 39129297)
9. Tsuge M, Hiraga N, Takaishi H, et al. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis B virus. Hepatology 2005; 42:1046-54. (Pubitemid 43112671)
10. Hiraga N, Imamura M, Tsuge M, et al. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon. FEBS Lett 2007; 581:1983-7. (Pubitemid 46680431)
11. Kimura T, Imamura M, Hiraga N, et al. Establishment of an infectious genotype 1b hepatitis C virus clone in human hepatocyte chimeric mice. J Gen Virol 2008; 89:2108-13.
12. Walters KA, Joyce MA, Thompson JC, et al. Application of functional genomics to the chimeric mouse model of HCV infection: optimization of microarray protocols and genomics analysis. Virol J 2006; 3:37.
13. Luster AD, Jhanwar SC, Chaganti RS, Kersey JH, Ravetch JV. Interferon-inducible gene maps to a chromosomal band associated with a (4;11) translocation in acute leukemia cells. Proc Natl Acad Sci U S A 1987; 84:2868-71. (Pubitemid 17064740)
14. Tong HH, Long JP, Li D, DeMaria TF. Alteration of gene expression in human middle ear epithelial cells induced by influenza A virus and its implication for the pathogenesis of otitis media. Microb Pathog 2004; 37:193-204. (Pubitemid 39349043)
15. Viala J, Chaput C, Boneca IG, et al. Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat Immunol 2004; 5:1166-74. (Pubitemid 39549631)